Tag: Anesthesia drugs

According to research, the use of nerve blocks as a form of regional anesthesia is increasing due to its ability to provide targeted pain relief while potentially reducing opioid consumption. Injections for a nerve block typically involve a local anesthetic, which may be combined with an array of other drugs, known as adjuvants, to modify the block's effect.

First introduced in 1948, Decamethonium was a pioneering neuromuscular blocking agent for surgical anesthesia. It is most commonly known by its former brand name, Syncurine, and the shorthand C10. The drug was pivotal in the evolution of muscle relaxants but was ultimately replaced by safer, more controllable alternatives.

Over 75,000 Americans undergo conscious sedation each year for dental procedures alone, a common application for what is colloquially known as the **drug twilight**. Contrary to the name, 'twilight' is not a single drug but a state of moderate sedation achieved with a combination of medications to help patients remain comfortable and relaxed during minor medical or surgical procedures. This approach is favored for its quicker recovery and reduced risks compared to general anesthesia.